Cresset Asset Management’s Nuvation Bio NUVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Buy |
143,690
+4,874
| +4% | +$9.5K | ﹤0.01% | 1331 |
|
|
2025
Q1 | $244K | Buy |
138,816
+2,381
| +2% | +$4.19K | ﹤0.01% | 1414 |
|
|
2024
Q4 | $363K | Buy |
136,435
+2,145
| +2% | +$5.71K | ﹤0.01% | 1225 |
|
|
2024
Q3 | $308K | Buy |
134,290
+7,140
| +6% | +$16.4K | ﹤0.01% | 1757 |
|
|
2024
Q2 | $371K | Hold |
127,150
| – | – | ﹤0.01% | 1563 |
|
|
2024
Q1 | $463K | Buy |
127,150
+100
| +0.1% | +$364 | ﹤0.01% | 1350 |
|
|
2023
Q4 | $192K | Sell |
127,050
-1,163
| -0.9% | -$1.76K | ﹤0.01% | 1674 |
|
|
2023
Q3 | $172K | Sell |
128,213
-640
| -0.5% | -$858 | ﹤0.01% | 1614 |
|
|
2023
Q2 | $232K | Buy |
128,853
+1,703
| +1% | +$3.07K | ﹤0.01% | 1529 |
|
|
2023
Q1 | $211K | Hold |
127,150
| – | – | ﹤0.01% | 733 |
|
|
2022
Q4 | $244K | Sell |
127,150
-68,900
| -35% | -$132K | ﹤0.01% | 591 |
|
|
2022
Q3 | $440K | Hold |
196,050
| – | – | 0.01% | 548 |
|
|
2022
Q2 | $636K | Hold |
196,050
| – | – | 0.01% | 490 |
|
|
2022
Q1 | $1.03M | Hold |
196,050
| – | – | 0.01% | 401 |
|
|
2021
Q4 | $1.67M | Buy |
196,050
+9,000
| +5% | +$76.5K | 0.02% | 328 |
|
|
2021
Q3 | $1.86M | Hold |
187,050
| – | – | 0.03% | 245 |
|
|
2021
Q2 | $1.74M | Buy |
187,050
+60,000
| +47% | +$558K | 0.02% | 232 |
|
|
2021
Q1 | $1.33M | Buy |
+127,050
| New | +$1.33M | 0.02% | 233 |
|